Anti-CD19 chimeric antigen receptor T-cell therapy for relapsed or refractory Philadelphia chromosome-positive B cell acute lymphoblastic leukemia: a multicenter retrospective study
The preliminary study was presented as a poster presentation (Publication Number: 4201) at the 66th American Society of Hematology Annual Meeting, San Diego, CA, on December 7-10, 2024.
Authors
- Xingbing Wang (ORCID: https://orcid.org/0000-0002-5591-2168)
- Jinglei Yu
- Yuhua Li (ORCID: https://orcid.org/0000-0002-0982-6680)
- Fengmei Song (ORCID: https://orcid.org/0000-0003-1123-9407)
- He Huang
- Wei Sang
- Mingming Zhang
- Guoqing Wei
- Yongxian Hu
- Lixin Wang
- Songfu Jiang
- Mingfeng Zhao
- Sanfang Tu
Institutions
- University of Science and Technology of China (CN)
- Xuzhou Medical College (CN)
- Nankai University (CN)
- Wenzhou Medical University (CN)
- Tianjin First Center Hospital (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Immunité et Cancer (FR)
- Cell Technology (China) (HK)
- Zhujiang Hospital (CN)
- Zhejiang Lab (CN)
- Anhui Provincial Hospital (CN)
- Shenzhen University Health Science Center (CN)
- Zhejiang University-University of Edinburgh Institute (CN)
- First Affiliated Hospital Zhejiang University (CN)
- Tianjin Medical University (CN)
- Southern Medical University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- BMC Medicine
- Published
- 2026-03-03
- DOI
- https://doi.org/10.1186/s12916-026-04755-6
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00